Molecular Vision Limited

Device Transactions Medical device companies raised a total of $1.1 billion during the first quarter of 2012, a 40% increase over Q4 2011’s $800 million, and a much stronger start to the year than 201

Alliances Financings Elsevier’s Strategic Transactions

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abingdon Health Ltd. Molecular Vision Ltd. Abingdon Health Ltd. has purchased a 50.1% equity stake in fellow private diagnostics firm Molecular Vision

By Beth Detuzzi Mergers & Acquisitions Alcon Inc. (a division ofNestle SA) & Novartis AG Novartis AG announced that it will pay $39bn over the next three years to acquire a 77% stake in Nestle